Al Mamun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Al Mamun has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jaytirmoy Barmon
BCSIR Rajshahi Laboratories, Bangladesh Council of Scientific and Industrial Research, Rajshahi 6206, Bangladesh
2 shared publications - Mst. Hajera Khatun
Department of Pharmacy, School of Science and Technology Varendra University Rajshahi Bangladesh
2 shared publications Afiqul Islam
Department of Paediatric Haematology and Oncology, Labaid Cancer Hospital, Dhaka, Bangladesh
1 shared publication- Anwarul Haque
Department of Pharmacy, Faculty of Science University of Rajshahi Rajshahi Bangladesh
1 shared publication - Ariful Islam
Department of Pharmacy, School of Science and Technology, Varendra University, Rajshahi 6204, Bangladesh
1 shared publication - Ashikur Rahman
Department of Pharmacy, School of Science and Technology, Varendra University, Rajshahi 6204, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Scientifica
- Vol. 2025 (1) , 6516268
Unveiling Pharmacological Promise of Mangifera indica (Haribhanga) Peel Extract: Exploring an Untapped Cultivar Through Biochemical and Computational Approaches
The Haribhanga is one of the most renowned varieties of mango native to the Rangpur region of Bangladesh. The study aimed to explore the in vitro and in vivo pharmacological potentialities of the methanolic extract of Mangifera indica (Haribhanga) (MEMI) peel. The antioxidant, antimicrobial, and antiarthritic activities of MEMI peel were conducted by the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) free radical scavenging, disc diffusion, and protein denaturation assays, respectively. The extract was administered to STZ‐induced diabetic mice for 7 days for the observation of blood glucose, body weight, lipid profile, and liver enzyme levels. The gas chromatography–mass spectrometry (GC–MS) analysis was performed to identify phytochemicals in the extract. Subsequently, molecular docking was conducted to predict the binding affinity of the identified compounds. The MEMI peel exhibited notable antioxidant potentiality with an IC 50 value of 4.43 ± 0.68 μg/mL and antimicrobial activity against Bacillus cereus with a zone of inhibition of 20.67 ± 1.52 mm. Furthermore, MEMI peel demonstrated substantial antiarthritic activity, with the highest inhibition of denaturation of protein (88%) observed at the highest dose (500 μg/mL). In the in vivo experiments, MEMI peel led to a significant increase in high‐density lipoprotein ( p < 0.001, p < 0.05), with a significant decrease in blood glucose ( p < 0.001), triglycerides, total cholesterol, and low‐density lipoprotein ( p < 0.0001) in STZ‐induced diabetic mice. Comparing the diabetic control mice, the MEMI peel substantially decreased ( p < 0.001) the high serum levels of aspartate aminotransferase and alanine aminotransferase. Moreover, the extract significantly improved the body weight ( p < 0.001) of diabetic mice after 7 days of treatment. GC‐MS analysis identified 28 bioactive compounds, primarily fatty acid esters in the MEMI peel. Di‐n‐octyl phthalate, terpinen‐4‐ol, 8,11,14‐docosatrienoic acid methyl ester, and phenol, 2‐methoxy‐4‐(2‐propenyl)‐acetate exhibited the most favorable binding potential in molecular docking studies. The results suggest that MEMI peel possesses antimicrobial, antiarthritic, antidiabetic, antihyperlipidemic, and liver enzyme protective activities as a promising antioxidant.
- 1 January 2025
- Published by Wiley in Scientifica
- Vol. 2025 (1) , 6516268
Open AccessUnveiling Pharmacological Promise of Mangifera indica (Haribhanga) Peel Extract: Exploring an Untapped Cultivar Through Biochemical and Computational Approaches
The Haribhanga is one of the most renowned varieties of mango native to the Rangpur region of Bangladesh. The study aimed to explore the in vitro and in vivo pharmacological potentialities of the methanolic extract of Mangifera indica (Haribhanga) (MEMI) peel. The antioxidant, antimicrobial, and antiarthritic activities of MEMI peel were conducted by the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) free radical scavenging, disc diffusion, and protein denaturation assays, respectively. The extract was administered to STZ‐induced diabetic mice for 7 days for the observation of blood glucose, body weight, lipid profile, and liver enzyme levels. The gas chromatography–mass spectrometry (GC–MS) analysis was performed to identify phytochemicals in the extract. Subsequently, molecular docking was conducted to predict the binding affinity of the identified compounds. The MEMI peel exhibited notable antioxidant potentiality with an IC 50 value of 4.43 ± 0.68 μg/mL and antimicrobial activity against Bacillus cereus with a zone of inhibition of 20.67 ± 1.52 mm. Furthermore, MEMI peel demonstrated substantial antiarthritic activity, with the highest inhibition of denaturation of protein (88%) observed at the highest dose (500 μg/mL). In the in vivo experiments, MEMI peel led to a significant increase in high‐density lipoprotein ( p < 0.001, p < 0.05), with a significant decrease in blood glucose ( p < 0.001), triglycerides, total cholesterol, and low‐density lipoprotein ( p < 0.0001) in STZ‐induced diabetic mice. Comparing the diabetic control mice, the MEMI peel substantially decreased ( p < 0.001) the high serum levels of aspartate aminotransferase and alanine aminotransferase. Moreover, the extract significantly improved the body weight ( p < 0.001) of diabetic mice after 7 days of treatment. GC‐MS analysis identified 28 bioactive compounds, primarily fatty acid esters in the MEMI peel. Di‐n‐octyl phthalate, terpinen‐4‐ol, 8,11,14‐docosatrienoic acid methyl ester, and phenol, 2‐methoxy‐4‐(2‐propenyl)‐acetate exhibited the most favorable binding potential in molecular docking studies. The results suggest that MEMI peel possesses antimicrobial, antiarthritic, antidiabetic, antihyperlipidemic, and liver enzyme protective activities as a promising antioxidant.
- Open Access
- 10 June 2023
- Published by Scientific Research and Community Ltd in Journal of Pediatrics Research Reviews & Reports
- Vol. 5 (3) , 1-2
Serial Blood Cultures in Neutropenic Children with Persistent Fever After Conventional Chemotherapy in Bangladesh: Their Usefulness
When the initial blood culture reveals no bacterial growth, the primary goal of the study is to ascertain the prevalence of bacteremia in patients admitted with febrile neutropenia and to assess patient risk factors for this occurrence. A prospective cross-sectional study was conducted. 90 children with febrile neutropenia who are being treated at Bangabandhu’s Paediatrics, Hemato-Oncology Department will participate in the trial. Medical Sheikh Mujib Medical University, during the period of July’22 to December’22. Data will be collected in a questionnaire with informed written consent. Data will be presented in graph and probability values of <0.05 will be considered as statistically significant for all results. Admitted patients were selected with purposive sampling technique the primary end point was to assess the blood bacterial isolates in patients with febrile neutropenia. The mean age was found 6.9±3.1 years with range from 2.5 years to 15 years. About the diagnosis, more than half of the patients patients had ALL diagnosis followed by AML and then NHL diagnosis (p = 0.043). The mean duration of neutropenia was found 10.8±6.67 days with rang from 3 to 30 days. The 2 times mean number of episode fever was found 1.2±0.4 time varied from Regarding the blood culture islolates, growth was not found in 2nd sample and 3rd sample.
- 10 June 2023
- Published by Scientific Research and Community Ltd in Journal of Pediatrics Research Reviews & Reports
- Vol. 5 (3) , 1-2
Open AccessSerial Blood Cultures in Neutropenic Children with Persistent Fever After Conventional Chemotherapy in Bangladesh: Their Usefulness
When the initial blood culture reveals no bacterial growth, the primary goal of the study is to ascertain the prevalence of bacteremia in patients admitted with febrile neutropenia and to assess patient risk factors for this occurrence. A prospective cross-sectional study was conducted. 90 children with febrile neutropenia who are being treated at Bangabandhu’s Paediatrics, Hemato-Oncology Department will participate in the trial. Medical Sheikh Mujib Medical University, during the period of July’22 to December’22. Data will be collected in a questionnaire with informed written consent. Data will be presented in graph and probability values of <0.05 will be considered as statistically significant for all results. Admitted patients were selected with purposive sampling technique the primary end point was to assess the blood bacterial isolates in patients with febrile neutropenia. The mean age was found 6.9±3.1 years with range from 2.5 years to 15 years. About the diagnosis, more than half of the patients patients had ALL diagnosis followed by AML and then NHL diagnosis (p = 0.043). The mean duration of neutropenia was found 10.8±6.67 days with rang from 3 to 30 days. The 2 times mean number of episode fever was found 1.2±0.4 time varied from Regarding the blood culture islolates, growth was not found in 2nd sample and 3rd sample.
- Open Access
- 1 March 2022
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 47-52
THE METHANOLIC EXTRACT OF MIMOSA PIGRA LEAVES REDUCES THE SEVERITY OF DIARRHEA AS WELL AS INHIBITS THE GROWTH OF DIARRHEA-CAUSING BACTERIA
Objective: Diarrhea is a major global health issue that has become increasingly prevalent in developing countries. In Bangladesh, Mimosa pigra L. is used traditionally for the treatment of diarrhea and also to control infection. Our main objective was to evaluate whether the methanolic extract of Mimosa pigra (MEMP) leaves has the antidiarrheal effect as well as the antibacterial effect against diarrhea-causing bacteria. Methods: The antibacterial potentialities of MEMP leaves were investigated by the disc diffusion method against six Gram-positive and six Gram-negative bacteria at 500 μg/disc. Kanamycin (30 μg/disc) was used as the standard drug. Antidiarrheal activities of leaf extracts were determined at two doses (200 and 400 mg/kg) in a castor oil and magnesium sulfate-induced diarrheal model in mice. The results were evaluated by One-Way Analysis of Variance (ANOVA) followed by Dunnet’s test. **P<0.01 and ***P<0.001 were considered significant compared to control. Results: The MEMP leaves exhibited moderate to potent antimicrobial activity with the zone of inhibition range 11 to 17 mm against diarrhea causing bacteria such as Salmonella paratyphi (16.33 mm), Salmonella typhi (17 mm), Shigella boydii (12 mm), Shigella dysenteriae (12.67 mm) and Escherichia coli (11 mm). Furthermore the severity of diarrhea was significantly reduced (P<0.001) by MEMP leaves at a dose of 400 mg/kg (13±2.16) compared to control (30.25±2.87) by castor oil-induced method. The same dose of the extract also significantly inhibited (P<0.01) the severity of diarrhea (14.75±1.71) compared to control (24±2.16) by magnesium sulfate-induced diarrheal model. The percent inhibition of diarrhea in 3h by MEMP leaves at a dose of 400 mg/kg was 57.02% and 38.54% in castor oil and magnesium sulfate-induced diarrheal model, respectively. Conclusion: Confirmed findings in this study naturally suggested that MEMP leaves could be an effective antibacterial and antidiarrheal formulation.
- 1 March 2022
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 47-52
Open AccessTHE METHANOLIC EXTRACT OF MIMOSA PIGRA LEAVES REDUCES THE SEVERITY OF DIARRHEA AS WELL AS INHIBITS THE GROWTH OF DIARRHEA-CAUSING BACTERIA
Objective: Diarrhea is a major global health issue that has become increasingly prevalent in developing countries. In Bangladesh, Mimosa pigra L. is used traditionally for the treatment of diarrhea and also to control infection. Our main objective was to evaluate whether the methanolic extract of Mimosa pigra (MEMP) leaves has the antidiarrheal effect as well as the antibacterial effect against diarrhea-causing bacteria. Methods: The antibacterial potentialities of MEMP leaves were investigated by the disc diffusion method against six Gram-positive and six Gram-negative bacteria at 500 μg/disc. Kanamycin (30 μg/disc) was used as the standard drug. Antidiarrheal activities of leaf extracts were determined at two doses (200 and 400 mg/kg) in a castor oil and magnesium sulfate-induced diarrheal model in mice. The results were evaluated by One-Way Analysis of Variance (ANOVA) followed by Dunnet’s test. **P<0.01 and ***P<0.001 were considered significant compared to control. Results: The MEMP leaves exhibited moderate to potent antimicrobial activity with the zone of inhibition range 11 to 17 mm against diarrhea causing bacteria such as Salmonella paratyphi (16.33 mm), Salmonella typhi (17 mm), Shigella boydii (12 mm), Shigella dysenteriae (12.67 mm) and Escherichia coli (11 mm). Furthermore the severity of diarrhea was significantly reduced (P<0.001) by MEMP leaves at a dose of 400 mg/kg (13±2.16) compared to control (30.25±2.87) by castor oil-induced method. The same dose of the extract also significantly inhibited (P<0.01) the severity of diarrhea (14.75±1.71) compared to control (24±2.16) by magnesium sulfate-induced diarrheal model. The percent inhibition of diarrhea in 3h by MEMP leaves at a dose of 400 mg/kg was 57.02% and 38.54% in castor oil and magnesium sulfate-induced diarrheal model, respectively. Conclusion: Confirmed findings in this study naturally suggested that MEMP leaves could be an effective antibacterial and antidiarrheal formulation.